May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is
May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases...
